Moreover, it has been observed that even a small increase in serum levels of irisin could limit the probability of developing breast cancer up to 90% [50], while higher levels of irisin in serum act in a protective manner against spinal metastasis in female breast cancer patients [51]. The gene discussed is FNDC5; the disease is breast cancer.